biuro@scopefluidics.com +48 22 376 21 14
biuro@scopefluidics.com +48 22 376 21 14
biuro@scopefluidics.com +48 22 376 21 14

RAPORT ESPI 8/2019 | 28-06-2019 | Zakończenie czwartego etapu prac badawczo-rozwojowych nad systemem PCR|ONE

Previous PostNext Post

Related Posts

15.10.2026

Edocera develops device prototype and confirms its ability to detect signs of stroke

0
30.09.2026

Scope Fluidics after the first half of 2026: strong cash position, IVDR certification and expanding cooperation with distributors

0
28.09.2026

Hybolic signs PARP funding agreement to develop a system for measuring insulin and glucose concentrations

0